- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Neurotrophic keratitis.
Displaying page 1 of 1.
EudraCT Number: 2015-003326-13 | Sponsor Protocol Number: BTI-011-EC/15/QUER | Start Date*: 2016-01-05 |
Sponsor Name:BTI Biotechnology Institute I mas D | ||
Full Title: Randomized, parallel groups, multicenter and blind to evaluators clinical trial, to evaluate the efficacy and safety of PRGF-Endoret eye drops, in patients with stage 2 and 3 neurotrophic keratitis. | ||
Medical condition: Neurotrophic Keratitis (NK) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001841-23 | Sponsor Protocol Number: I.2016.010 | Start Date*: 2016-11-16 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A multicenter, randomized, open-label, two-arms phase I/II clinical trial to asses efficacy and safety of cord blood eye drops in neurotrophic keratopathy | |||||||||||||
Medical condition: Neurotrophic Keratitis, stage 2 or 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002527-15 | Sponsor Protocol Number: NGF0212 | Start Date*: 2013-03-01 | |||||||||||
Sponsor Name:Dompé farmaceutici s.p.a | |||||||||||||
Full Title: Study Brand Name : REPARO Study full title: An 8-week phase I/II, multicenter, randomized, double-masked, vehicle controlled parallel group study with a 48 or 56 week follow-up period to evaluat... | |||||||||||||
Medical condition: Adult patients diagnosed with unilateral stage 2 (persistent epithelial defect) and stage 3 (corneal ulcer) NK refractory to one or more conventional non-surgical treatments. Patients with Controla... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) PT (Completed) HU (Completed) ES (Completed) PL (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002475-34 | Sponsor Protocol Number: REC0559-B-001 | Start Date*: 2020-03-03 | |||||||||||
Sponsor Name:Recordati Rare Diseases | |||||||||||||
Full Title: Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients | |||||||||||||
Medical condition: Neurotrophic Keratitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FR (Completed) GB (GB - no longer in EU/EEA) DE (Completed) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
